Targeted-release budesonide for treating primary IgA nephropathy

Evaluation committee members

The 5 technology appraisal committees are standing advisory committees of NICE. This topic was considered as a streamlined evaluation by the lead team of the highly specialised technologies evaluation committee, which includes the chair.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chair

Paul Arundel
Chair, highly specialised technologies evaluation committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Catherine Spanswick
Technical lead

Alan Moore
Technical adviser

Thomas Feist
Project manager

Richard Diaz
Associate director

ISBN: 978-1-4731-9220-1